Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 60


Pro Claims in Fibromyalgia: A Review of the Labels of Products Approved by the Fda and the Ema.

Acquadro C, Perret C, Regnault A.

Value Health. 2015 Nov;18(7):A653. doi: 10.1016/j.jval.2015.09.2353. Epub 2015 Oct 20. No abstract available.


Health-related quality of life in patients with prominent negative symptoms: results from a multicenter randomized Phase II trial on bitopertin.

Rofail D, Regnault A, le Scouiller S, Berardo CG, Umbricht D, Fitzpatrick R.

Qual Life Res. 2015 Jul 5. [Epub ahead of print]


Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries.

Bosch AM, Burlina A, Cunningham A, Bettiol E, Moreau-Stucker F, Koledova E, Benmedjahed K, Regnault A.

Orphanet J Rare Dis. 2015 Jun 18;10:80. doi: 10.1186/s13023-015-0294-x.


Cross-cultural adaptation of the Schizophrenia Caregiver Questionnaire (SCQ) and the Caregiver Global Impression (CaGI) Scales in 11 languages.

Rofail D, Acquadro C, Izquierdo C, Regnault A, Zarit SH.

Health Qual Life Outcomes. 2015 Jun 9;13:76. doi: 10.1186/s12955-015-0264-y.


Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients' and parents' quality of life: the phenylketonuria - quality of life (PKU-QOL) questionnaires.

Regnault A, Burlina A, Cunningham A, Bettiol E, Moreau-Stucker F, Benmedjahed K, Bosch AM.

Orphanet J Rare Dis. 2015 May 10;10:59. doi: 10.1186/s13023-015-0261-6.


Impact of cytokine in type 1 narcolepsy: Role of pandemic H1N1 vaccination ?

Lecendreux M, Libri V, Jaussent I, Mottez E, Lopez R, Lavault S, Regnault A, Arnulf I, Dauvilliers Y.

J Autoimmun. 2015 Jun;60:20-31. doi: 10.1016/j.jaut.2015.03.003. Epub 2015 Apr 16.


Impact of severe haemophilia A on patients' health status: results from the guardian(™) 1 clinical trial of turoctocog alfa (NovoEight(®) ).

Ozelo M, Chowdary P, Regnault A, Busk AK.

Haemophilia. 2015 Jul;21(4):451-7. doi: 10.1111/hae.12617. Epub 2015 Feb 12.


Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures.

Anthoine E, Moret L, Regnault A, Sébille V, Hardouin JB.

Health Qual Life Outcomes. 2014 Dec 9;12:176. doi: 10.1186/s12955-014-0176-2. Review.


The "psychomicrobiotic": Targeting microbiota in major psychiatric disorders: A systematic review.

Fond G, Boukouaci W, Chevalier G, Regnault A, Eberl G, Hamdani N, Dickerson F, Macgregor A, Boyer L, Dargel A, Oliveira J, Tamouza R, Leboyer M.

Pathol Biol (Paris). 2015 Feb;63(1):35-42. doi: 10.1016/j.patbio.2014.10.003. Epub 2014 Nov 2. Review.


Pooling of cross-cultural PRO data in multinational clinical trials: how much can poor measurement affect statistical power?

Regnault A, Hamel JF, Patrick DL.

Qual Life Res. 2015 Feb;24(2):273-7. doi: 10.1007/s11136-014-0765-x. Epub 2014 Sep 5.


Using quantitative methods within the Universalist model framework to explore the cross-cultural equivalence of patient-reported outcome instruments.

Regnault A, Herdman M.

Qual Life Res. 2015 Jan;24(1):115-24. doi: 10.1007/s11136-014-0722-8. Epub 2014 Jun 4.


Refractory Chronic Pain Screening Tool (RCPST): a feasibility study to assess practicality and validity of identifying potential neurostimulation candidates.

Baron R, Backonja MM, Eldridge P, Levy R, Vissers K, Attal N, Buchser E, Cruccu G, De Andrés J, Hansson P, Jacobs M, Loeser JD, Prager JP, Stanton Hicks M, Regnault A, Van den Abeele C, Taylor RS.

Pain Med. 2014 Feb;15(2):281-91. doi: 10.1111/pme.12272. Epub 2013 Nov 8.


Assessment of the impact of treatment on quality of life of patients with haemophilia A at different ages: insights from two clinical trials on turoctocog alfa.

Santagostino E, Lentz SR, Busk AK, Regnault A, Iorio A.

Haemophilia. 2014 Jul;20(4):527-34. doi: 10.1111/hae.12371. Epub 2014 Jan 29.


Development of a questionnaire to assess the impact on parents of their infant's bronchiolitis hospitalization.

Lapillonne A, Regnault A, Gournay V, Gouyon JB, Benmedjahed K, Anghelescu D, Arnould B, Moriette G.

BMC Health Serv Res. 2013 Jul 12;13:272. doi: 10.1186/1472-6963-13-272.


Impact on parents of bronchiolitis hospitalization of full-term, preterm and congenital heart disease infants.

Lapillonne A, Regnault A, Gournay V, Gouyon JB, Gilet H, Anghelescu D, Miloradovich T, Arnould B, Moriette G.

BMC Pediatr. 2012 Oct 31;12:171. doi: 10.1186/1471-2431-12-171.


Validation of the Dutch version of the DN4 diagnostic questionnaire for neuropathic pain.

van Seventer R, Vos C, Giezeman M, Meerding WJ, Arnould B, Regnault A, van Eerd M, Martin C, Huygen F.

Pain Pract. 2013 Jun;13(5):390-8. doi: 10.1111/papr.12006. Epub 2012 Oct 31.


Validation of the Treatment Satisfaction Questionnaire for Medication in patients with cystic fibrosis.

Regnault A, Balp MM, Kulich K, Viala-Danten M.

J Cyst Fibros. 2012 Dec;11(6):494-501. doi: 10.1016/j.jcf.2012.04.007. Epub 2012 May 12.


Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: results from the VISTA trial.

Delforge M, Dhawan R, Robinson D Jr, Meunier J, Regnault A, Esseltine DL, Cakana A, van de Velde H, Richardson PG, San Miguel JF.

Eur J Haematol. 2012 Jul;89(1):16-27. doi: 10.1111/j.1600-0609.2012.01788.x. Epub 2012 May 7.


User centered and ontology based information retrieval system for life sciences.

Sy MF, Ranwez S, Montmain J, Regnault A, Crampes M, Ranwez V.

BMC Bioinformatics. 2012 Jan 25;13 Suppl 1:S4. doi: 10.1186/1471-2105-13-S1-S4.


Treatment satisfaction instruments for different purposes during a product's lifecycle: keeping the end in mind.

Rofail D, Taylor F, Regnault A, Filonenko A.

Patient. 2011;4(4):227-40. doi: 10.2165/11595280-000000000-00000. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk